Retina (Philadelphia, Pa.)۲٬۰۲۶مطالعه مشاهده اینمایه شده در PubMed
Robert J Campbell, Sherif R El-Defrawy, Sudeep S Gill, Jonas Shellenberger, Marlo Whitehead, Chaim M Bell, Susan E Bronskill, J Michael Paterson, Michael A McIsaac
چکیده
Systemically administered anticancer vascular endothelial growth factor inhibiting therapies can cause severe kidney injury. Intravitreal aflibercept has a greater impact on renal vascular endothelial growth factor levels than ranibizumab. We compared the risk of kidney injury among patients…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1097/iae.0000000000004653